Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
6.04
-0.07 (-1.15%)
At close: Aug 18, 2025, 3:59 PM
6.19
2.57%
After-hours: Aug 18, 2025, 05:55 PM EDT

Solid Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 8.09M 13.62M
Cost of Revenue
2.46M 2.58M 2.41M 2.96M
Gross Profit
-2.46M -2.58M 5.69M 10.66M
Operating Income
-129.73M -104.31M -106.45M -72.25M
Interest Income
9.47M 7.14M 2.62M 64K
Pretax Income
-124.7M -96.02M -85.98M -72.19M
Net Income
-124.7M -96.02M -85.98M -72.19M
Selling & General & Admin
33.3M 27.75M 21.67M 27.14M
Research & Development
96.43M 76.56M 78.42M 58.74M
Other Expenses
-2.46M -2.58M -63.96M -2.96M
Operating Expenses
127.27M 101.73M 36.13M 82.91M
Interest Expense
340K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
129.73M 104.31M 114.55M 85.87M
Income Tax Expense
n/a n/a -20.47M -64K
Shares Outstanding (Basic)
40.82M 19.88M 8.51M 7.12M
Shares Outstanding (Diluted)
40.82M 19.88M 8.51M 7.12M
EPS (Basic)
-3.06 -4.83 -10.1 -10.13
EPS (Diluted)
-3.06 -4.83 -10.1 -10.13
EBITDA
-121.9M -93.43M -96.87M -69.29M
EBIT
-124.36M -96.02M -99.27M -72.25M
Depreciation & Amortization
2.46M 2.58M 2.41M 2.96M